Short-term effects of fibrinolytic therapy on the hemodynamic parameters of patients with intermediate- and high-risk pulmonary embolism
Clinical and Experimental Emergency Medicine. 2022;9(1):47-53 
Mean arterial pressure within 24 hours of admission predicts short-term prognosis in patients with intermediate-risk and high-risk pulmonary embolism
. 2020;
Mean arterial pressure within 24 hours of admission predicts short-term prognosis in patients with intermediate-risk and high-risk pulmonary embolism
. 2020;
Systemic Fibrinolytic Therapy Versus Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute İntermediate-High Risk Pulmonary Embolism
The American Journal of Cardiology. 2021;141:153-154
Short- and long-term prognostic role of diastolic blood pressure in intermediate-high risk patients with acute pulmonary embolism
European Journal of Internal Medicine. 2018;55:e23-e24
CRT-300.04 Short- and Long-Term Outcomes of Catheter-Based Therapies in Patients With Intermediate-/High-Risk Pulmonary Embolism – A Multicenter Retrospective Cohort Study
JACC: Cardiovascular Interventions. 2023;16(4):S51
Adding clinical markers of more severe form of intermediate-high risk pulmonary embolism improves risk stratification and possibly identifies candidates for fibrinolytic therapy
European Heart Journal. Acute Cardiovascular Care. 2022;11(Supplement_1):
Short-term prognostic value of clinical data in hospitalized patients with intermediate-risk acute pulmonary embolism
. 2022;
Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy
Case Reports in Anesthesiology. 2020;2020:1-5
Management of the High-Risk Pulmonary Embolism in the Acute Phase—Respiratory, Hemodynamic and Mechanical Support
Pulmonary Embolism. 2021;129-142